SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
10
03
2020
accepted:
07
05
2020
pubmed:
21
5
2020
medline:
22
6
2021
entrez:
21
5
2020
Statut:
epublish
Résumé
To date, there are no network meta-analyses comparing the impact of as-needed treatments in asthma, including the single maintenance and reliever therapy (known as "SMART" or "MART"; for simplicity, SMART will be used hereafter) and the use of inhaled corticosteroid (ICS)/long-acting β
Identifiants
pubmed: 32430423
pii: 13993003.00625-2020
doi: 10.1183/13993003.00625-2020
pii:
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Anti-Asthmatic Agents
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: P. Rogliani reports grants and personal fees from Boehringer Ingelheim, Novartis, Chiesi Farmaceutici and Almirall, personal fees from AstraZeneca, Biofutura, GlaxoSmithKline, Menarini and Mundipharma, grants from Zambon, outside the submitted work. Conflict of interest: B.L. Ritondo has nothing to disclose. Conflict of interest: J. Ora has nothing to disclose. Conflict of interest: M. Cazzola reports grants and personal fees from Boehringer Ingelheim, Novartis, Almirall and Zambon, personal fees from AstraZeneca, Chiesi Farmaceutici, ABC Farmaceutici, Edmond Pharma, Verona Pharma, Ockham Biotech, Biofutura, GlaxoSmithKline, Menarini, Lallemand, Mundipharma and Pfizer, outside the submitted work. Conflict of interest: L. Calzetta reports grants and personal fees from Boehringer Ingelheim, Novartis and Zambon, non-financial support from AstraZeneca, grants from Chiesi Farmaceutici and Almirall, personal fees from ABC Farmaceutici, Edmond Pharma, Verona Pharma and Ockham Biotech, outside the submitted work.